IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation
Journal of Cell Biology · 2024
DOI: 10.1083/jcb.202302048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Yohei Iguchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Frontotemporal Dementia, Frontotemporal Lobar Degeneration. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, SERIKA.
Abstract (Originalsprache)
Cytoplasmic aggregation of TDP-43 in neurons is a pathological feature common to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). We demonstrate that the IκB kinase (IKK) complex promotes the degradation of cytoplasmic TDP-43 through proteasomes. While IKKβ is a major factor in TDP-43 degradation, IKKα acts as a cofactor, and NEMO functions as a scaffold for the recruitment of TDP-43 to the IKK complex. Furthermore, we identified IKKβ-induced phosphorylation sites of TDP-43 and found that phosphorylation at Thr8 and Ser92 is important for the reduction of TDP-43 by IKK. TDP-43 phosphorylation at Ser92 was detected in a pattern different from that of C-terminal phosphorylation in the pathological inclusion of ALS. IKKβ was also found to significantly reduce the expression level and toxicity of the disease-causing TDP-43 mutation. Finally, the favorable effect of IKKβ on TDP-43 aggregation was confirmed in the hippocampus of mice. IKK and the N-terminal phosphorylation of TDP-43 are potential therapeutic targets for ALS and FTLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Medical Faculty, Institute of Experimental Epileptology and Cognition Research, University of Bonn, Bonn, Germany.
- Section of Viral Vector Development, National Institute for Physiological Sciences, Okazaki, Japan.
- Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Yohei Iguchi, Yuhei Takahashi, Jiayi Li, Kunihiko Araki, Yoshinobu Amakusa, Yu Kawakami, Kenta Kobayashi, Satoshi Yokoi, Masahisa Katsuno
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- SERIKA
- Japan ALS Association
- Takeda Science Foundation
Zitieren
APA
Iguchi, Y., Takahashi, Y., Li, J., Araki, K., Amakusa, Y., Kawakami, Y., Kobayashi, K., Yokoi, S., & Katsuno, M. (2024). IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation. Journal of Cell Biology. https://doi.org/10.1083/jcb.202302048
Vancouver
Iguchi Y, Takahashi Y, Li J, Araki K, Amakusa Y, Kawakami Y, et al. IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation. Journal of Cell Biology. 2024. doi:10.1083/jcb.202302048
BibTeX
@article{Iguchi2024,
author = {Iguchi, Yohei and Takahashi, Yuhei and Li, Jiayi and Araki, Kunihiko and Amakusa, Yoshinobu and Kawakami, Yu and Kobayashi, Kenta and Yokoi, Satoshi and Katsuno, Masahisa},
title = {IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation},
journal = {Journal of Cell Biology},
year = {2024},
doi = {10.1083/jcb.202302048}
}
EUVIMED